Chirantan Chatterjee is an associate professor in economics and strategy at the Indian Institute of Management, Ahmedabad, where he also holds the ICICI Bank Chair in Strategic Management. In 2019, Chatterjee was awarded the IIM Ahmedabad VVEF Outstanding Researcher Award. Chatterjee is also a 2018-2019 recipient of the prestigious W. Glenn Campbell and Rita Ricardo-Campbell National Fellowship award, at the Hoover Institution, Stanford University. He was also additionally appointed in 2019 as the Edward Teller National Fellow at Hoover Institution, Stanford University. He is currently a Visiting Fellow at the Hoover Institution for the period 2019-2021.
Earlier, Chatterjee was a faculty member in economics and public policy at the Indian School of Business. At ISB he was a Bharti Institute & Max Institute Research Fellow in Public Policy & Healthcare. Before his ISB stint, Chatterjee was a faculty member between 2011 and 2017 with IIM Bangalore where he held the Young Faculty Research Chair. Chatterjee earned a Ph.D. & an M.Phil. in public policy and management from the Heinz College, Carnegie Mellon University. He has a B.Tech. in civil engineering from the Indian Institute of Technology, Roorkee and a MBA from the Indian Institute of Management, Calcutta. Between 2003 & 2005, after his MBA, Chatterjee worked as a business journalist for The Economic Times, India.
Chatterjee's research employs insights from empirical industrial organization, applied microeconomics and strategic foundations of industries, to examine the trade-offs between access, innovation and welfare in global pharmaceutical & healthcare markets. His work is published in global peer- reviewed outlets like the RAND Journal of Economics, Journal of Health Economics, The Journal of Law & Economics, Research Policy, Production and Operations Management, Journal of Business Ethics, Harvard Business Review, Social Science & Medicine, Health Policy and Planning, Economic and Political Weekly and Journal of Antitrust Enforcement. His work has also been published by Brookings Press and NBER.
His dissertation work on the economics of innovation and IP in the global pharmaceutical industry was supported by the National Science Foundation, and in 2015 his research was cited on the NSF Science of Science Policy website. In the past Chatterjee’s research has also been supported by Pfizer’s International Policy Unit. Some of his current research explore 1) the incentives for innovation in Indian vaccine markets given health shocks like pandemics 2) the role of behavioral biases in emerging world demand for pharmaceutical (and other) fairness creams 3) the market impact of pharmaceutical relabeling in the US 4) the role of regulatory interventions like Orphan Drug Act in facilitating efficient investor-investee matches in bio-pharmaceutical entrepreneurship and 5) impact of stronger patents on wage inequality in Indian manufacturing firms.
Chatterjee has also been invited for research seminars at universities around the world including UC Berkeley, Stanford University (Hoover IP2 conference 2016 and 2017), University of Pennsylvania's LDI Research Seminar Series & India & Innovation Conference, NBER Summer Institute & Productivity Meetings, the 2016 Lifesciences Symposium by Bates & White, Georgia Institute of Technology, London Business School, National University of Singapore, Institute of Innovation Research at Hitotsubashi University, Peking University HSBC Business School, Indian Statistical Institute, Delhi & Kolkata and Indian Institute of Management at Ahmedabad and Kolkata. In the past, Chatterjee has consulted for the World Bank (on Universal Healthcare Coverage in India) & Competition Commission of the Government of India (on Indian pharmaceutical markets). His inputs were cited by the NITI Aayog, India’s central planning authority in a 2015 report on innovation and entrepreneurship policy for the economy.
Chatterjee has been actively involved in executive education with healthcare executives and leaders conducting programs as faculty director and instructor with Johnson & Johnson (on Indian hospital markets), with Novartis (on women healthcare leaders in India), with Novo Nordisk (on Indian pharmaceutical industry & health economics) and with Wockhardt, Jubilant, & Micro-Labs (on growth strategies and managerial economics). In addition he also co-created the executive teaching program on Management of Technology Innovation listed on The Economist.
In 2015, Chatterjee conceptualized and chaired the 1st India Conference on Innovation, Intellectual Property & Competition, a first of its kind international innovation policy conference in India supported by Qualcomm Inc. & Tata Trusts. This conference witnessed noted scholars on global institutions and innovation presenting their work and thoughts on Innovation in India, including David Teece, Tarun Khanna, Stuart Graham, Lee Branstetter, Kamal Saggi and Zorina Khan among others. In addition industry leaders and policy makers also presented their thoughts. In 2018, this conference reconvened at the Indian School of Business with a key note speech from Mr. Suresh Prabhu, Minister of Commerce & Industry and Civil Aviation, Government of India. Chatterjee was the co-chair in the 2018 version with prominent international scholars in innovation policy and the global economy presenting their work.
Chatterjee's deep passion about Indian healthcare markets and for democratizing education has also resulted in the first ever MOOC on healthcare markets in India in 2016 available through edX. He has also been a visiting faculty member at IIM Visakhapatnam. He enjoys regularly contributing policy and managerial Op-Eds at outlets like Vox-EU, The Hill, Livemint, Economic Times, Times of India, India Abroad, DNA India, & Hindustan Times. During his spare time, Chatterjee is occupied with his family and 5 year old son while dabbling willy-nilly in experimental cooking at their home kitchen.